Double-blind Randomized Controlled Trial in Severe Alcoholic Hepatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

January 31, 2011

Conditions
Alcoholic HepatitisAlcoholic Liver Disease
Interventions
DRUG

Pentoxifylline

400 mg prolonged-released tablets 3 time per day for 1 month.

DRUG

placebo

prolonged-release tablets 3 time per day for 1 month

Trial Locations (28)

1070

University hospital, Brussels

14000

University hospital, Caen

33000

University hospital, Bordeaux

34295

University hospital, Montpellier

35033

University hospital, Rennes

45000

University hospital, Nantes

49000

University hospital, Poitiers

49933

University hospital, Angers

54511

University hospital, Nancy, Vandœuvre-lès-Nancy

59037

University hospital, Lille

59100

Centre Hospitalier Victor Provo, Roubaix

59208

Centre Hospitalier, Tourcoing

59240

Centre hospitalier, Dunkirk

59300

Centre Hospitalier, Valenciennes

59600

Centre hospitalier Sambre en avesnois, Maubeuge

60100

Centre Hospitalier, Creil

62300

Centre Hospitalier, Lens

62408

Centre hospitalier, Béthune

67100

University Hospital, Strasbourg

75012

Hôpital Saint Antoine (AP-HP), Paris

75013

Hôpital de la Pitié-Salpétrière (AP-HP), Paris

75014

Hôpital Cochin (AH-HP), Paris

92118

Hôpital Beaujon (AH-HP), Clichy

92141

Hospital Antoine Béclère (Assistance Publique des Hôpiaux de Paris), Clamart

93143

Hôpital Jean Verdier (AH-HP), Bondy

94000

Hôpital Henri Mondor (AP-HP), Créteil

Hôpital Paul Brousse (AH-HP), Villejuif

06202

University hospital, Nice

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

lead

University Hospital, Lille

OTHER

NCT01214226 - Double-blind Randomized Controlled Trial in Severe Alcoholic Hepatitis | Biotech Hunter | Biotech Hunter